Literature DB >> 21489649

A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus.

Ivana Stojanovic1, Ivana Mirkov, Milena Kataranovski, Jasmina Glamoclija, Stanislava Stosic-Grujicic.   

Abstract

Inflammation plays an important role in protective immunity against fungi, including the opportunistic pathogen, Aspergillus fumigatus. The balance between pro-inflammatory and anti-inflammatory cytokines is a key determinant of infection outcome. Since macrophage migration inhibitory factor (MIF) is an upstream regulator of many cytokines, we analyzed herein the role of endogenous MIF in the host control of hematogenously disseminated aspergillosis using MIF⁻/⁻ mice. As revealed by their mortality rate, MIF⁻/⁻ mice were more susceptible to disseminated infection than WT mice. Moreover, pharmacologic inhibition of MIF with (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester, (ISO-1) increased the susceptibility of WT mice to lethal infection. The higher tissue fungal burden early in sublethal infection indicated increased susceptibility of MIF⁻/⁻ mice to sublethal infection as well. Substantial down-regulation of innate and acquired antifungal responses, characterized by decreased production of IL-1β, IL-6, TNF-α, IFN-γ and IL-17 in the spleen was noted in sublethally infected MIF⁻/⁻ mice. In contrast, IL-4 was higher in MIF⁻/⁻ than in WT mice. Taken together, our findings show that MIF contributes to host resistance against progressive invasive A. fumigatus infection by controlling downstream pro-inflammatory versus anti-inflammatory cytokine production thus determining the outcome of infection.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21489649     DOI: 10.1016/j.imbio.2011.03.005

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

Review 1.  Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.

Authors:  I Mirkov; S Stosic-Grujicic; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo.

Authors:  Khaled Khoufache; Sylvie Bazin; Karine Girard; Julie Guillemette; Marie-Christine Roy; Jean-Pierre Verreault; Yousef Al-Abed; Warren Foster; Ali Akoum
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

Review 3.  Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

4.  Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation.

Authors:  Tali Lang; Jacinta P W Lee; Kirstin Elgass; Anita A Pinar; Michelle D Tate; Elizabeth H Aitken; Huapeng Fan; Sarah J Creed; Nadia S Deen; Daouda A K Traore; Ivo Mueller; Danielle Stanisic; Francesca S Baiwog; Colin Skene; Matthew C J Wilce; Ashley Mansell; Eric F Morand; James Harris
Journal:  Nat Commun       Date:  2018-06-08       Impact factor: 14.919

Review 5.  Role of the Macrophage Migration Inhibitory Factor in the Pathophysiology of Pre-Eclampsia.

Authors:  Tullia Todros; Luana Paulesu; Simona Cardaropoli; Alessandro Rolfo; Bianca Masturzo; Leonardo Ermini; Roberta Romagnoli; Francesca Ietta
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

Review 6.  The multifaceted roles of NLRP3-modulating proteins in virus infection.

Authors:  James Harris; Natalie A Borg
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

7.  Immunomodulatory effect of an isolated fraction from Tinospora crispa on intracellular expression of INF-γ, IL-6 and IL-8.

Authors:  Walaa Najm Abood; Iman Fahmi; Mahmood Ameen Abdulla; Salmah Ismail
Journal:  BMC Complement Altern Med       Date:  2014-06-27       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.